These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 21309176)
1. [Drug control of appetite]. Makoundou V; Golay A Rev Med Suisse; 2011 Jan; 7(277):57-60. PubMed ID: 21309176 [TBL] [Abstract][Full Text] [Related]
2. Can gut hormones control appetite and prevent obesity? Chaudhri OB; Wynne K; Bloom SR Diabetes Care; 2008 Feb; 31 Suppl 2():S284-9. PubMed ID: 18227498 [TBL] [Abstract][Full Text] [Related]
3. Gut hormones in the control of appetite. Murphy KG; Bloom SR Exp Physiol; 2004 Sep; 89(5):507-16. PubMed ID: 15184357 [TBL] [Abstract][Full Text] [Related]
5. Neuro-hormonal control of food intake: basic mechanisms and clinical implications. Konturek PC; Konturek JW; Cześnikiewicz-Guzik M; Brzozowski T; Sito E; Konturek SJ J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():5-25. PubMed ID: 16340035 [TBL] [Abstract][Full Text] [Related]
6. Drug strategies for the treatment of obesity. Alemany M; Remesar X; Fernández-López JA IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679 [TBL] [Abstract][Full Text] [Related]
8. The development of tolerance to drugs that suppress food intake. Fernstrom JD; Choi S Pharmacol Ther; 2008 Jan; 117(1):105-22. PubMed ID: 17950459 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and pharmacologic treatment of obesity: the role of energy regulatory mechanism. Manulu MS; Sutanegara IN Acta Med Indones; 2006; 38(1):42-50. PubMed ID: 16479031 [TBL] [Abstract][Full Text] [Related]
10. Anti-obesity drugs: use, mechanisms and clinical importance. Adam O; Forth W Int J Clin Pharmacol Ther; 2001 Jun; 39(6):232-8. PubMed ID: 11430630 [TBL] [Abstract][Full Text] [Related]
11. The pharmacologic management of obesity. Cerda JJ J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231 [No Abstract] [Full Text] [Related]
12. Neuropharmacology of human appetite expression. Halford JC; Harrold JA Dev Disabil Res Rev; 2008; 14(2):158-64. PubMed ID: 18646016 [TBL] [Abstract][Full Text] [Related]
17. [Clinical experience with the use of phenyltert-butylamine (phentermine) as an appetite depressant in the treatment of obesity]. Lobato DS; da Silveira DD Hospital (Rio J); 1966 Nov; 70(5):1343-50. PubMed ID: 5301950 [No Abstract] [Full Text] [Related]
18. The mechanism of action for oxyntomodulin in the regulation of obesity. Wynne K; Field BC; Bloom SR Curr Opin Investig Drugs; 2010 Oct; 11(10):1151-7. PubMed ID: 20872318 [TBL] [Abstract][Full Text] [Related]
19. High demand likely for prescription weight-control drugs. Mayo Clin Health Lett; 2012 Nov; 30(11):4. PubMed ID: 23795359 [No Abstract] [Full Text] [Related]